FLOYD ERIC enters VIRPAX PHARMACEUTICALS, INC. with 3.54K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 2/16/2021ACC: 0001213900-21-009793
3.54K
Baseline shares
100% direct
3.54K
Direct ownership
1 position
39.34K
Derivative underlying
3 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock, $0.00001 par value per share
DirectShares owned3.54K
Total
3.54K direct3.54K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, $0.00001 par value per share | 3.54K | Direct |
| Total | 3.54K | 3.54K direct |
Derivative Holdings3
Stock Option (right to buy)
DirectUnderlying security
Common Stock, $0.00001 par value per share
Underlying shares
20.23K
Shares owned
N/A
Exercise price
9.89
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying security
Common Stock, $0.00001 par value per share
Underlying shares
9.38K
Shares owned
N/A
Exercise price
9.89
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying security
Common Stock, $0.00001 par value per share
Underlying shares
9.73K
Shares owned
N/A
Exercise price
9.89
Expiration
—
Exercise window
—
Total
Underlying
39.34K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock, $0.00001 par value per share | 9.89 | — | — | 20.23K | N/A |
| Stock Option (right to buy) Direct | Common Stock, $0.00001 par value per share | 9.89 | — | — | 9.38K | N/A |
| Stock Option (right to buy) Direct | Common Stock, $0.00001 par value per share | 9.89 | — | — | 9.73K | N/A |
| Total | 39.34K | 0.00 | ||||